June 3, 2016
For immediate release
Life Science Innovation Network Japan, Inc.
Mitsui Fudosan Co., Ltd.

LINK-J Founded to Promote Life Science Innovation
through Industry-Academia-Government Collaboration
In cooperation with the University of California, San Diegoand Biocom, a life sciences association
Mitsui Fudosan Co., Ltd. (Chuo-ku, Tokyo, President and CEO: Masanobu Komoda) and interested
members in academia are pleased to announce the foundation of Life Science Innovation NetworkJapan, Inc. (Chuo-ku, Tokyo, Chairman of the Board: Hideyuki Okano, Dean, Keio University
School of Medicine / hereinafter referred to as LINK-J) . LINK-J, based in the Nihonbashi district
where a cluster of medical and pharmaceutical-related companies is situated, will start its activities
to promote open innovation through industry-academia-government collaboration to support thecreation of new industries.
■About LINK－J
The life sciences constitute an interdisciplinary nexus linking all areas of scientific endeavor. They
encompass medicine, the natural sciences, engineering; and such new technologies as ICT and AI.
LINK-J has been established to promote national and international cross-disciplinary interaction ofhuman resources and technologies and provide support to seeds and ideas leading to practicalapplication through its network.
Dr. Hideyuki Okano, Dean, Keio University School of Medicine, has assumed the office of theChairman of the Board of LINK-J, and Dr. Yoshiki Sawa, Dean, Osaka University Graduate Schoolof Medicine/ Faculty of Medicine, Vice Chairman of the Board.
Moreover, the Management Advisory Committee that provides advice to LINK-J’s business
operations is participated by 13 experts from industry and academia, including Dr. Yoichiro
Matsumoto, Executive Director, RIKEN, and Dr. Shinya Yamanaka, Director, Center for iPS Cell
Research and Application (CiRA), Kyoto University.
LINK-J will recruit those who endorse the purpose of its establishment as LINK-J members (specialmembers), starting from July 2016. LINK-J will provide special members opportunities to participate
in symposiums, seminars and other gatherings for the interaction of members as its “Interaction andCollaboration Business.” Moreover, it will offer individuals aiming to start a business and startup
companies programs and places for receiving advice, opportunities to raise funds from investors
and matching opportunities for business alliance as its “Development and Assistance Business.”
LINK-J will promote bi-directional collaboration between Japan and abroad with overseas
universities and institutions that are taking the lead in the area of life sciences. As a start, we haveagreed with the University of California, San Diego (UC San Diego) on collaboration in the area oflife sciences. Furthermore, collaboration with Biocom, a life sciences association, also located in
San Diego, has been fixed. Collaboration with UC San Diegoand Biocom will help promote therevitalization of life science innovation in Japan.

UC San Diego

Dr. Albert P. Pisano
Jacobs School of Engineering
UC San Diego* About UC San Diego
One of the largest clusters of life science companies and academic institutions in the United States has beendeveloped in San Diego, California. UC San Diego is known not only for its advanced research anddevelopment system in life sciences, but also for a proud record of leading the life science cluster in the formof industry academia collaboration.
* About Biocom
Biocom is also a membership organization consisting of 750 life science-related companies and groups with
its headquarters in San Diego. Biocom plays a central role in the ecosystem (an environment that generates acluster of new industries) of life science innovation.

■ Mitsui Fudosan’s activities
Mitsui Fudosan regards the creation of new industries for a broader business area as an importantstrategy. The “Nihonbashi Life Science Innovation Promotion Project” implemented together with
LINK-J will be a pillar for the creation of new industries, along with the “new industry creation in
Kashiwa-no-ha Smart City” and “31 VENTURES, a co-creation project implemented
collaboratively with startup companies.” Mitsui Fudosan, through the urban development in
Nihonbashi, continuously offers both place and opportunity (tangible and intangible requirements)
to encourage national and international/industry-government-academia collaboration for therevitalization of life science innovation.

There are now three bases for the Nihonbashi Life Science Innovation Promotion Project, as
Nihonbashi Life Science Building2 has been newly added to the existing Nihonbashi Life Science
Building and Nihonbashi Life Science Hub. It has already been decided that the US San Diego
Tokyo Branch and Medical-Industrial Cooperation Support Office of Tokyo Metropolitan
Government (tentative name) will be located in the Nihonbashi Life Science Building (2-3-11,Nihonbashi Honcho, Chuo-ku, Tokyo) whose current tenants include industrial groups andbranches of Osaka University, Kyoto University, the University of Tokyo and Tohoku University.
The Department of Innovative Drug Discovery and Development, Japan Agency for Medical
Research and Development (AMED) is a tenant of the Nihonbashi Life Science Hub (8F.,Muromachi Chibagin Mitsui Building, 1-5-5, Nihombashi Muromachi, Chuo-ku, Tokyo) andpromising life science startup companies are tenants of Nihonbashi Life Science Building2 (3-11-5,Nihonbashi Honcho, Chuo-ku, Tokyo). More than 100 seminars, symposiums, and other eventswere held in the above places of interaction during the past 12 months. With the start of LINK-J,
further interactions are expected in the three bases in Nihonbashi now and in the future.
Nihonbashi Life Science Building2(31VENTURES Life Bridge Nihonbashi)

Nihonbashi Life Science Building

Nihonbashi Life Science Hub

In Nihonbashi, Mitsui Fudosan will establish a life science hub, enhance the capability to support
global business, and moreover, in collaboration with LINK-J, develop an environment whereinnovators inside and outside Japan meet and co-create, crossing the border of their respective
fields. Mitsui Fudosan encourages the generation of life science innovation and supports thecreation of new industries in order to further increase the value of Nihonbashi, and at the same time,
contribute to the solution of issues related to the health and longevity of people of the world.

【Attachment No.1】【Overview of LINK-J】
Corporate nameLife Science Innovation Network Japan, Inc.

Incorporated inMarch 2016

Executive Officers

Chairman of the Board: Hideyuki Okano (Dean, Keio University School of Medicine)
Vice Chairman of the Board: Yoshiki Sawa (Dean, Osaka University Graduate School ofMedicine/Faculty of Medicine)
Director: Takashi Ueda (Executive Managing Officer, Mitsui Fudosan Co., Ltd.)
Auditor: Yutaro Kikuchi (Attorney at law, Kikuchi Sogo Law Office)(LINK-J)

Special Advisor: Yoichiro Matsumoto(Executive Director, RIKEN)
Special Advisor: Shinya Yamanaka(Director, Center for iPS Cell Research and Application (CiRA), Kyoto University)
Special Advisor: Peter F. Cowhey(Dean, School of Global Policy and Strategy, University of California, San Diego)

Management Advisory
Committee

Advisor: Shinji Asonuma(Executive Vice-President for Industry-Government-Academia Collaboration, KyotoUniversity)
Advisor: Hideo Shindo(Executive Vice President for Industry-University Collaboration, Tohoku University)
Advisor: Masayo Tada
(President, The Federation of Pharmaceutical Manufacturers' Associations ofJAPAN (FPMAJ))
Advisor: Yuzo Toda
(Chairman, Forum for Innovative Regenerative Medicine (FIRM))(Director and Executive Vice President, Fujifilm Corporation)
Advisor: Koji Nakao(Chairman, The Japan Federation of Medical Devices Associations (JFMDA))
Director and Corporate Advisor, Terumo Corporation)
Advisor: Yoshihiko Hatanaka(President, Japan Pharmaceutical Manufacturers Association (JPMA))(President and CEO, Astellas Pharma Inc.)
Advisor: Toshiaki Higashihara(President & CEO, Hitachi, Ltd.)
Advisor: Masaaki Mizuno(Presidential Advisor/Professor, Nagoya University)
Advisor: Toshiya Watanabe(Professor, Policy Alternatives Research Institute)
Advisor: Masanobu Komoda(President and CEO, Mitsui Fudosan Co., Ltd.)【Attachment No.2】【Profile of Hideyuki Okano, Chairman of the Board】

March 1983
October 1989

Graduated from Keio University School of Medicine
Enrolled in the Johns Hopkins University School of Medicine Department of Biological Chemistry,
U.S.A. (Laboratory of Dr. Craig Montell)
September 1994
Professor, Department of Molecular Neurobiology, Institute of Basic Medical Sciences, University ofTsukuba
April 1997
Professor, Division of Neuroanatomy, Osaka University Graduate School of Medicine(from April 1999: Professor, Osaka University Graduate School of Medicine due to the reorganization for a greater focus
on graduate schools）
April 2001
Professor, Department of Physiology, Keio University School of Medicine
April 2015-Present Dean, Keio University School of Medicine
Expertise in: Molecular Neurobiology, Developmental Biology, Regenerative Medicine

【Attachment No.3】【Outline of 3 Buildings in Nihonbashi(As of June 1st)】
1. Nihonbashi Life Science Hub(1) Address

1-5-5, Nihombashi Muromachi, Chuo-ku, Tokyo 103-0022
8F., Muromachi Chibagin Mitsui Building(2)Floor area

Approximately 1,030 ㎡(3)TenantsFloor
8th floor

Japan Agency for Medical Research and Development(Department of Innovative Drug Discovery and Development, East Japan Office）
Conference room（rental meeting room）, Communication lounge

2. Nihonbashi Life Science Building(1)Address

2-3-11, Nihonbashi Honcho, Chuo-ku, Tokyo, 103-0023(2)Floor area

Approximately 6,240 ㎡(3)Tenants
Floor
10th floor

Conference room (rental meeting room), Communication loungeLife Science Innovation Network Japan, Inc.(LINK-J)

9th floor
8th~9th floor
6th floor

5th floor
4th floor

3rd floor~1stfloor

UC San Diego, Osaka University, Kyoto University, The University of Tokyo, andTohoku University
Japan Pharmaceutical Manufacturers Association
Forum for Innovative Regenerative Medicine (FIRM)Tokyo Metropolitan Government (Medical Device Development Center/ Medical,
Industry and Academia Collaboration(tentative)
DIA Japan
Japanese Organization for Medical Device Development, Inc.
Pharmaceutical Development Support Center
The Japanese CRO Association
MinaCare Co.,Ltd.
General Incorporated Associations Health Care Stability and Regional Economy
Vitalization Forum
Quantum Biosystems Inc.
The Systems Biology InstituteTsujimaru International Patent Office
The Japanese Society for Regenerative Medicine
Biopharma Forest Inc.
Conference room (rental meeting room), reception desk, etc.

3. Nihonbashi Life Science Building 2(1) Address(2)Floor area

3-11-5, Nihonbashi Honcho, Chuo-ku, Tokyo, 103-0023
Approximately 1,340 ㎡（Floor 5~7）

(3) Tenants
Floor
6Th floor

INDEE Medical
KinoPharma Inc.
Delta-Fly Pharma Inc.
Commons for Medicine and Engineering JapanMed Vision